A detailed history of Brewin Dolphin LTD transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Brewin Dolphin LTD holds 77 shares of AVNS stock, worth $1,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77
Previous 77 -0.0%
Holding current value
$1,233
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Nov 14, 2022

BUY
$29.25 - $36.02 $2,252 - $2,773
77 New
77 $3,000
Q2 2019

Nov 09, 2023

SELL
$37.68 - $46.52 $1,017 - $1,256
-27 Reduced 11.3%
212 $9.25 Million
Q4 2018

Nov 09, 2023

SELL
$41.16 - $66.67 $699 - $1,133
-17 Reduced 6.64%
239 $10.7 Million
Q3 2018

Nov 09, 2023

BUY
$55.13 - $72.65 $9,868 - $13,004
179 Added 232.47%
256 $17.5 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.